Mary is an advanced trainee in General Paediatrics/Community and Developmental Paediatrics. Has called Townsville home for the last decade. Outside of work, she enjoys eating and Crossfit (one of 'those people'!)

Autism spectrum disorder (Part 4) – We have a diagnosis…what’s next?

Uncategorized
Cite this article as:
Hardimon, M. Autism spectrum disorder (Part 4) – We have a diagnosis…what’s next?, Don't Forget the Bubbles, 2018. Available at:
http://doi.org/10.31440/DFTB.15458

After meeting with Charlie and his family multiple times and getting further history from his daycare, you determine that Charlie does indeed have autism. You remember that early intervention programs have been shown to improve overall outcome but aren’t sure where to start 

Autism spectrum disorder (Part 2) – why is this happening to me?!

Cite this article as:
Hardimon, M. Autism spectrum disorder (Part 2) – why is this happening to me?!, Don't Forget the Bubbles, 2018. Available at:
http://doi.org/10.31440/DFTB.15447

You have been referred Charlie, a 2yo boy, by his general practitioner who suspects that he has autism. He attends your room with his mother who feels helpless surrounding this potential “label” that is being considered for her son. She has a list of questions however her first one is “why is this happening to…

Autism spectrum disorder (part 1) – what’s in a name?

Cite this article as:
Hardimon, M. Autism spectrum disorder (part 1) – what’s in a name?, Don't Forget the Bubbles, 2018. Available at:
http://doi.org/10.31440/DFTB.15442

Since being first described by Dr Leo Kanner of John Hopkin’s University in 1943, the terminology used in the diagnosis and reference to autism spectrum disorder has changed multiple times making it confusing not only for families but also clinicians.

Guanfacine

Cite this article as:
Hardimon, M. Guanfacine, Don't Forget the Bubbles, 2017. Available at:
http://doi.org/10.31440/DFTB.13727

On 22nd August 2017, guanfacine hydrochloride (current sole brand name Intuniv) was accepted as a new chemical entity by the Therapeutic Goods Administration in Australia.1 Whilst new to Australia, guanfacine has been available within the United States of America and Europe since 20102 and 20153 respectively. The development of generic brands within these countries has…

Fetal Alcohol Spectrum Disorder – Management

Cite this article as:
Hardimon, M. Fetal Alcohol Spectrum Disorder – Management, Don't Forget the Bubbles, 2017. Available at:
http://doi.org/10.31440/DFTB.12615

After taking an extensive history and performing multiple clinical examinations in consultation with allied health staff, you come to the conclusion that Callum has a diagnosis of foetal alcohol spectrum disorder. His mother is mortified about the situation and isn’t sure what this will mean for Callum (both now and in the future) as well…